Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2022. Start Trial.
Date Value
October 26, 2026 1.654
October 23, 2026 1.654
October 22, 2026 1.654
October 21, 2026 1.654
October 20, 2026 1.654
October 19, 2026 1.654
October 16, 2026 1.654
October 15, 2026 1.654
October 14, 2026 1.654
October 13, 2026 1.654
October 12, 2026 1.654
October 09, 2026 1.654
October 08, 2026 1.654
October 07, 2026 1.545
October 06, 2026 1.545
October 05, 2026 1.545
October 02, 2026 1.545
October 01, 2026 1.545
September 30, 2026 1.545
September 29, 2026 1.545
September 28, 2026 1.545
September 25, 2026 1.545
September 24, 2026 1.545
September 23, 2026 1.545
September 22, 2026 1.545
Date Value
September 21, 2026 1.545
September 18, 2026 1.545
September 17, 2026 1.545
September 16, 2026 1.545
September 15, 2026 1.545
September 14, 2026 1.639
September 11, 2026 1.584
September 10, 2026 1.338
September 09, 2026 1.338
September 08, 2026 1.338
September 04, 2026 1.338
September 03, 2026 1.338
September 02, 2026 1.338
September 01, 2026 1.338
August 31, 2026 1.338
August 28, 2026 1.338
August 27, 2026 1.338
August 26, 2026 1.338
August 25, 2026 1.338
August 24, 2026 1.338
August 21, 2026 1.338
August 20, 2026 1.338
August 19, 2026 1.338
August 18, 2026 1.338
August 17, 2026 1.338

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Novo Nordisk A/S 5.111
ALK-Abello A/S 7.627
AstraZeneca PLC 11.27
ANI Pharmaceuticals, Inc. 2.793
Corcept Therapeutics, Inc. 13.32

Price to Book Value Related Metrics